Cardiac resynchronization therapy in NYHA class IV heart failure.
Khoo M, Kelly PA, Lindenfeld J.
Curr Cardiol Rep. 2009 May;11(3):175-83. doi: 10.1007/s11886-009-0026-8.
Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the EuroSMR Registry.
Stocker TJ, Stolz L, Karam N, Kalbacher D, Koell B, Trenkwalder T, Xhepa E, Adamo M, Spieker M, Horn P, Butter C, Weckbach LT, Novotny J, Melica B, Giannini C, von Bardeleben RS, Pfister R, Praz F, Lurz P, Rudolph V, Metra M, Hausleiter J; EuroSMR Investigators.
JACC Cardiovasc Interv. 2024 Nov 11;17(21):2543-2554. doi: 10.1016/j.jcin.2024.08.016.
Cardiac devices in patients with transthyretin amyloidosis: Impact on functional class, left ventricular function, mitral regurgitation, and mortality.
Donnellan E, Wazni OM, Saliba WI, Baranowski B, Hanna M, Martyn M, Patel D, Trulock K, Menon V, Hussein A, Aagaard P, Jaber W, Kanj M.
J Cardiovasc Electrophysiol. 2019 Nov;30(11):2427-2432. doi: 10.1111/jce.14180. Epub 2019 Sep 25.
Assessing right ventricular function in patients with hypertrophic cardiomyopathy with cardiac MRI: correlation with the New York Heart Function Assessment (NYHA) classification.
Zhang S, Yang ZG, Sun JY, Wen LY, Xu HY, Zhang G, Guo YK.
PLoS One. 2014 Sep 2;9(9):e104312. doi: 10.1371/journal.pone.0104312. eCollection 2014.
Mitral reconstruction in cardiomyopathy.
Bolling SF.
J Heart Valve Dis. 2002 Jan;11 Suppl 1:S26-31.
Efficacy and Safety of Mavacamten in the Treatment of Hypertrophic Cardiomyopathy: A Systematic Review.
Bishev D, Fabara S, Loseke I, Alok A, Al-Ani H, Bazikian Y.
Heart Lung Circ. 2023 Sep;32(9):1049-1056. doi: 10.1016/j.hlc.2023.05.019. Epub 2023 Jul 14.
Transcatheter Edge-to-Edge Repair in Patients With Primary Tricuspid Regurgitation.
Sugiura A, Dreyfus J, Bombace S, Ivannikova M, Bartkowiak J, Haussig S, Schneider LM, Kassar M, Horn P, Taramasso M, Iliadis C, Osawa I, Goto T, Weber M, Tanaka T, Zimmer S, Obadia JF, Habib G, Bazire B, Iung B, Bohbot Y, Tribouilloy C, Donal E, Nejjari M, Riant E, Le Tourneau T, Lavie-Badie Y, Coisne A, Modine T, Lim P, Doguet F, Selton-Suty C, Baldus S, Kelm M, Praz F, Rottbauer W, Hans-Peter Linke A, Hahn R, Volker R, Messika-Zeitoun D, Lurz P, Nickenig G.
JACC Cardiovasc Interv. 2025 May 26;18(10):1289-1299. doi: 10.1016/j.jcin.2025.03.023.
Upgrading Right Ventricular Pacing to Cardiac Resynchronization in HFrEF Patients Improves Symptoms and Functional Outcomes.
Merkel E, Hatala R, Szigeti M, Schwertner W, Lakatos B, Behon A, Goscinska-Bis K, Milasinovic G, Papp R, Ruppert M, Sághy L, Clemens M, Solomon SD, Kutyifa V, Kovács A, Kosztin A, Merkely B.
JACC Heart Fail. 2025 Feb;13(2):265-273. doi: 10.1016/j.jchf.2024.09.011. Epub 2024 Nov 27.
Chronic Right Ventricular Pacing in the Heart Failure Population.
Gould J, Sieniewicz B, Porter B, Sidhu B, Rinaldi CA.
Curr Heart Fail Rep. 2018 Apr;15(2):61-69. doi: 10.1007/s11897-018-0376-x.
Mid-Term Outcome after Tricuspid Valve Replacement.
Cheng Y, Mo S, Wang K, Fan R, Liu Y, Li S, Zhang X, Yin S, Xu Y, Tang B, Wu Z.
Braz J Cardiovasc Surg. 2020 Oct 1;35(5):644-653. doi: 10.21470/1678-9741-2019-0215.
